Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 406

1.

GH3 auxin-amido synthetases alter the ratio of indole-3-acetic acid and phenylacetic acid in Arabidopsis.

Aoi Y, Tanaka K, Cook SD, Hayashi KI, Kasahara H.

Plant Cell Physiol. 2019 Dec 6. pii: pcz223. doi: 10.1093/pcp/pcz223. [Epub ahead of print]

PMID:
31808940
2.

Letter to the editor.

Cook SD, Dowling PC.

Mult Scler Relat Disord. 2019 Sep;34:164. doi: 10.1016/j.msard.2019.06.020. Epub 2019 Jun 19. No abstract available.

PMID:
31543259
3.

An Historical Review of Phenylacetic Acid.

Cook SD.

Plant Cell Physiol. 2019 Feb 1;60(2):243-254. doi: 10.1093/pcp/pcz004. Review.

PMID:
30649529
4.

Linking Auxin with Photosynthetic Rate via Leaf Venation.

McAdam SAM, Eléouët MP, Best M, Brodribb TJ, Murphy MC, Cook SD, Dalmais M, Dimitriou T, Gélinas-Marion A, Gill WM, Hegarty M, Hofer JMI, Maconochie M, McAdam EL, McGuiness P, Nichols DS, Ross JJ, Sussmilch FC, Urquhart S.

Plant Physiol. 2017 Sep;175(1):351-360. doi: 10.1104/pp.17.00535. Epub 2017 Jul 21.

5.

Stability of visual outcome between 2 and 5 years following corneal transplantation in the UK.

Chow SP, Hopkinson CL, Tole DM, Jones MN, Cook SD, John Armitage W; National Health Service Blood and Ocular Tissue Advisory Group and Contributing Ophthalmologists (OTAG Study 23).

Br J Ophthalmol. 2018 Jan;102(1):37-41. doi: 10.1136/bjophthalmol-2016-310129. Epub 2017 Jun 9.

PMID:
28600303
7.
8.

Auxin Biosynthesis: Are the Indole-3-Acetic Acid and Phenylacetic Acid Biosynthesis Pathways Mirror Images?

Cook SD, Nichols DS, Smith J, Chourey PS, McAdam EL, Quittenden L, Ross JJ.

Plant Physiol. 2016 Jun;171(2):1230-41. doi: 10.1104/pp.16.00454. Epub 2016 Apr 26.

9.

Long-Term Outcomes of High-Risk Keratoplasty in Patients Receiving Systemic Immunosuppression.

Chow SP, Cook SD, Tole DM.

Cornea. 2015 Nov;34(11):1395-9. doi: 10.1097/ICO.0000000000000615.

PMID:
26382894
10.

Hypophosphatemia is Associated with the Serial Administration of Triple-Dose Gadolinium to Patients for Brain MRI.

Wolansky LJ, Cadavid D, Punia V, Kim S, Cheriyan J, Haghighi M, Cook SD.

J Neuroimaging. 2015 May-Jun;25(3):379-83. doi: 10.1111/jon.12241. Epub 2015 Apr 13.

PMID:
25867798
11.

Fatal acute liver failure with hepatitis B virus infection during nataluzimab treatment in multiple sclerosis.

Hillen ME, Cook SD, Samanta A, Grant E, Quinless JR, Rajasingham JK.

Neurol Neuroimmunol Neuroinflamm. 2015 Feb 12;2(2):e72. doi: 10.1212/NXI.0000000000000072. eCollection 2015 Apr. No abstract available. Erratum in: Neurol Neuroimmunol Neuroinflamm. 2015 Apr;2(2):e97.

12.

Intraocular lens opacification after descemet stripping automated endothelial keratoplasty.

Ahad MA, Darcy K, Cook SD, Tole DM.

Cornea. 2014 Dec;33(12):1307-11. doi: 10.1097/ICO.0000000000000279.

PMID:
25343696
13.

Peripheral ulcerative keratitis and corneal melt: a 10-year single center review with historical comparison.

Knox Cartwright NE, Tole DM, Georgoudis P, Cook SD.

Cornea. 2014 Jan;33(1):27-31. doi: 10.1097/ICO.0000000000000008.

PMID:
24240486
14.

MRI outcomes with cladribine tablets for multiple sclerosis in the CLARITY study.

Comi G, Cook SD, Giovannoni G, Rammohan K, Rieckmann P, Sørensen PS, Vermersch P, Hamlett AC, Viglietta V, Greenberg SJ.

J Neurol. 2013 Apr;260(4):1136-46. doi: 10.1007/s00415-012-6775-0. Epub 2012 Dec 21.

PMID:
23263473
15.

Steroid drops after keratoplasty.

Ross AH, Knox-Cartwright NE, Armitage WJ, Cook SD, Tole DM.

Ophthalmology. 2012 Dec;119(12):2652; author reply 2652. doi: 10.1016/j.ophtha.2012.07.074. No abstract available.

PMID:
23207033
16.

Cause of death in MS: long-term follow-up of a randomised cohort, 21 years after the start of the pivotal IFNβ-1b study.

Goodin DS, Ebers GC, Cutter G, Cook SD, O'Donnell T, Reder AT, Kremenchutzky M, Oger J, Rametta M, Beckmann K, Knappertz V.

BMJ Open. 2012 Nov 30;2(6). pii: e001972. doi: 10.1136/bmjopen-2012-001972. Print 2012.

17.

Use of Magnetic Resonance Imaging as Well as Clinical Disease Activity in the Clinical Classification of Multiple Sclerosis and Assessment of Its Course: A Report from an International CMSC Consensus Conference, March 5-7, 2010.

Cook SD, Dhib-Jalbut S, Dowling P, Durelli L, Ford C, Giovannoni G, Halper J, Harris C, Herbert J, Li D, Lincoln JA, Lisak R, Lublin FD, Lucchinetti CF, Moore W, Naismith RT, Oehninger C, Simon J, Sormani MP.

Int J MS Care. 2012 Fall;14(3):105-14. doi: 10.7224/1537-2073-14.3.105.

18.

Impaired auxin biosynthesis in the defective endosperm18 mutant is due to mutational loss of expression in the ZmYuc1 gene encoding endosperm-specific YUCCA1 protein in maize.

Bernardi J, Lanubile A, Li QB, Kumar D, Kladnik A, Cook SD, Ross JJ, Marocco A, Chourey PS.

Plant Physiol. 2012 Nov;160(3):1318-28. doi: 10.1104/pp.112.204743. Epub 2012 Sep 7.

19.

Impact of inflammation on brain volume in multiple sclerosis.

Cheriyan J, Kim S, Wolansky LJ, Cook SD, Cadavid D.

Arch Neurol. 2012 Jan;69(1):82-8. doi: 10.1001/archneurol.2011.674.

PMID:
22232347
20.

Heterogeneity in longitudinal evolution of ring-enhancing multiple sclerosis lesions.

Qian P, Cadavid D, Wolansky LJ, Cook SD, Naismith RT.

Ann Neurol. 2011 Oct;70(4):668-9; author reply 669-70. doi: 10.1002/ana.22622. No abstract available.

21.

A second case of Marburg's variant of multiple sclerosis with vasculitis and extensive demyelination.

Elenein RG, Sharer LR, Cook SD, Pachner AR, Michaels J, Hillen ME.

Mult Scler. 2011 Dec;17(12):1531-8. doi: 10.1177/1352458511414042. Epub 2011 Aug 3.

PMID:
21816761
22.

Clinical consequences of MRI activity in treated multiple sclerosis.

Cadavid D, Kim S, Peng B, Skurnick J, Younes M, Hill J, Wolansky LJ, Cook SD.

Mult Scler. 2011 Sep;17(9):1113-21. doi: 10.1177/1352458511405375. Epub 2011 May 25.

PMID:
21613336
23.

A case-control study of risk factors for multiple sclerosis in Iran.

Alonso A, Cook SD, Maghzi AH, Divani AA.

Mult Scler. 2011 May;17(5):550-5. doi: 10.1177/1352458510397685. Epub 2011 Feb 15.

PMID:
21325015
24.

Antiviral treatment following penetrating keratoplasty for herpetic keratitis.

Goodfellow JF, Nabili S, Jones MN, Nguyen DQ, Armitage WJ, Cook SD, Tole DM.

Eye (Lond). 2011 Apr;25(4):470-4. doi: 10.1038/eye.2010.237. Epub 2011 Jan 28.

25.

Long-term topical steroid treatment after penetrating keratoplasty in patients with pseudophakic bullous keratopathy.

Ross AH, Jones MN, Nguyen DQ, Jaycock PD, Armitage WJ, Cook SD, Kaye SB, Tole DM; National Health Service Blood and Transplant Ocular Tissue Advisory Group and Contributing Ophthalmologists.

Ophthalmology. 2009 Dec;116(12):2369-72. doi: 10.1016/j.ophtha.2009.06.006. Epub 2009 Oct 7.

PMID:
19815284
26.

Serum levels of CXCL13 are elevated in active multiple sclerosis.

Festa ED, Hankiewicz K, Kim S, Skurnick J, Wolansky LJ, Cook SD, Cadavid D.

Mult Scler. 2009 Nov;15(11):1271-9. doi: 10.1177/1352458509107017. Epub 2009 Oct 5.

PMID:
19805441
27.

Correlation of computed tomography with histology in the assessment of periprosthetic defect healing.

Cook SD, Patron LP, Salkeld SL, Smith KE, Whiting B, Barrack RL.

Clin Orthop Relat Res. 2009 Dec;467(12):3213-20. doi: 10.1007/s11999-009-1087-0.

28.

New acute and chronic black holes in patients with multiple sclerosis randomised to interferon beta-1b or glatiramer acetate.

Cadavid D, Cheriyan J, Skurnick J, Lincoln JA, Wolansky LJ, Cook SD.

J Neurol Neurosurg Psychiatry. 2009 Dec;80(12):1337-43. doi: 10.1136/jnnp.2008.171090. Epub 2009 Aug 16.

PMID:
19687024
29.

An overview of gene-epigenetic-environmental contributions to MS causation.

Lincoln JA, Cook SD.

J Neurol Sci. 2009 Nov 15;286(1-2):54-7. doi: 10.1016/j.jns.2009.06.037. Epub 2009 Jul 19. Review.

PMID:
19616791
30.

The effects of blood and fat on Morse taper disassembly forces.

Lavernia CJ, Baerga L, Barrack RL, Tozakoglou E, Cook SD, Lata L, Rossi MD.

Am J Orthop (Belle Mead NJ). 2009 Apr;38(4):187-90.

PMID:
19440574
31.

The use of rituximab in refractory mucous membrane pemphigoid with severe ocular involvement.

Ross AH, Jaycock P, Cook SD, Dick AD, Tole DM.

Br J Ophthalmol. 2009 Apr;93(4):421-2, 548. doi: 10.1136/bjo.2007.129510. No abstract available.

PMID:
19321473
32.

Efficacy of treatment of MS with IFNbeta-1b or glatiramer acetate by monthly brain MRI in the BECOME study.

Cadavid D, Wolansky LJ, Skurnick J, Lincoln J, Cheriyan J, Szczepanowski K, Kamin SS, Pachner AR, Halper J, Cook SD.

Neurology. 2009 Jun 9;72(23):1976-83. doi: 10.1212/01.wnl.0000345970.73354.17. Epub 2009 Mar 11.

PMID:
19279320
33.

We should use magnetic resonance imaging to classify and monitor the course of multiple sclerosis.

Lincoln JA, Cadavid D, Pollard J, McLeod J, Prineas J, Dowling P, Cook SD.

Arch Neurol. 2009 Mar;66(3):412-4. doi: 10.1001/archneurol.2009.26. No abstract available.

PMID:
19273765
34.

Topical cyclosporin: a treatment for corneal graft rejection.

Ross AH, Cook SD.

Clin Exp Ophthalmol. 2008 Jul;36(5):399-400. doi: 10.1111/j.1442-9071.2008.01808.x. No abstract available.

PMID:
18925911
35.

The visual and refractive outcomes of combined and sequential penetrating keratoplasty, cataract extraction, and intraocular lens insertion.

Nguyen DQ, Mumford LL, Jones MN, Armitage WJ, Cook SD, Kaye SB, Tole DM.

Eye (Lond). 2009 Jun;23(6):1295-301. doi: 10.1038/eye.2008.301. Epub 2008 Oct 3.

PMID:
18836407
36.

Could Epstein-Barr virus or canine distemper virus cause multiple sclerosis?

Lincoln JA, Hankiewicz K, Cook SD.

Neurol Clin. 2008 Aug;26(3):699-715, viii. doi: 10.1016/j.ncl.2008.03.004. Review.

PMID:
18657722
37.

The effect of low-intensity pulsed ultrasound on autologous osteochondral plugs in a canine model.

Cook SD, Salkeld SL, Patron LP, Doughty ES, Jones DG.

Am J Sports Med. 2008 Sep;36(9):1733-41. doi: 10.1177/0363546508316766. Epub 2008 May 15.

PMID:
18483198
38.

Does orally administered doxycycline reach the tear film?

Smith VA, Khan-Lim D, Anderson L, Cook SD, Dick AD.

Br J Ophthalmol. 2008 Jun;92(6):856-9. doi: 10.1136/bjo.2007.125989. Epub 2008 May 6.

PMID:
18460541
39.

Outcomes of same-sizing versus oversizing donor trephines in keratoconic patients undergoing first penetrating keratoplasty.

Jaycock PD, Jones MN, Males J, Armitage WJ, Cook SD, Tole DM, Kaye SB; UK Transplant Ocular Tissue Advisory Group and Contributing Ophthalmologists.

Ophthalmology. 2008 Feb;115(2):268-75. doi: 10.1016/j.ophtha.2007.04.051.

PMID:
18164404
40.

Relapsing-remitting central nervous system disease in a young child.

Fellman DM, Cook SD.

Rev Neurol Dis. 2005 Fall;2(4):215-6, 220-2. No abstract available.

PMID:
17768787
41.

Internet-based cognitive testing in multiple sclerosis.

Younes M, Hill J, Quinless J, Kilduff M, Peng B, Cook SD, Cadavid D.

Mult Scler. 2007 Sep;13(8):1011-9. Epub 2007 Jul 10.

PMID:
17623730
42.

Cladribine in aggressive forms of multiple sclerosis.

Martinez-Rodriguez JE, Cadavid D, Wolansky LJ, Pliner L, Cook SD.

Eur J Neurol. 2007 Jun;14(6):686-9.

PMID:
17539951
43.

Changes in the balance of the tissue inhibitor of matrix metalloproteinases (TIMPs)-1 and -3 may promote keratocyte apoptosis in keratoconus.

Matthews FJ, Cook SD, Majid MA, Dick AD, Smith VA.

Exp Eye Res. 2007 Jun;84(6):1125-34. Epub 2007 Mar 7.

PMID:
17449031
44.

Approved drugs and their problems in patient care: routes of administration and dosing.

Cook SD.

J Neurol Sci. 2007 Aug 15;259(1-2):38-41. Epub 2007 Mar 23. Review.

PMID:
17362996
45.

Electrolysis-needle cauterization of corneal vessels in patients with lipid keratopathy.

Wertheim MS, Cook SD, Knox-Cartwright NE, Van DL, Tole DM.

Cornea. 2007 Feb;26(2):230-1.

PMID:
17251821
46.

Rheumatoid keratolysis: a series of 40 eyes.

Malik R, Culinane AB, Tole DM, Cook SD.

Eur J Ophthalmol. 2006 Nov-Dec;16(6):791-7.

PMID:
17191183
47.

Corneal transplant rejection following influenza vaccination.

Wertheim MS, Keel M, Cook SD, Tole DM.

Br J Ophthalmol. 2006 Jul;90(7):925. Review. No abstract available.

48.

Delayed hypersensitivity following intravenous lidocaine.

Hickey JR, Cook SD, Gutteridge G, Sansom JE.

Contact Dermatitis. 2006 Apr;54(4):215-6. No abstract available.

PMID:
16650099
49.

Multiple sclerosis: pathologic, clinical, and imaging updates.

Cook SD.

Rev Neurol Dis. 2006 Winter;3(1):23-8. Review.

PMID:
16596083
50.

Dapsone induced haemolytic anaemia in patients treated for ocular cicatricial pemphigoid.

Wertheim MS, Males JJ, Cook SD, Tole DM.

Br J Ophthalmol. 2006 Apr;90(4):516. No abstract available.

Supplemental Content

Support Center